Your Article Summary
RSB Spine Announces 510(k) Approval to Market the InterPlate(TM) Vertebral Body Replacement Implant System
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/28/06
RSB Spine, LLC, a privately held medical device company focused on developing innovative spinal implants, announced that the U.S. Food and Drug Administration has conditionally approved its 510(k) application to permit marketing of the InterPlate(TM) Vertebral Body Replacement System. Submissions for cervical and lumbar interbody indications will follow
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Genentech, 12/08/09
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Article Search
Sponsor


See Latest Articles


